These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 25036111
21. Computational studies of darunavir into HIV-1 protease and DMPC bilayer: necessary conditions for effective binding and the role of the flaps. Leonis G, Czyżnikowska Ż, Megariotis G, Reis H, Papadopoulos MG. J Chem Inf Model; 2012 Jun 25; 52(6):1542-58. PubMed ID: 22587384 [Abstract] [Full Text] [Related]
22. Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs. Tie Y, Boross PI, Wang YF, Gaddis L, Liu F, Chen X, Tozser J, Harrison RW, Weber IT. FEBS J; 2005 Oct 25; 272(20):5265-77. PubMed ID: 16218957 [Abstract] [Full Text] [Related]
23. Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens. Santos JR, Llibre JM, Imaz A, Domingo P, Iribarren JA, Mariño A, Miralles C, Galindo MJ, Ornelas A, Moreno S, Schapiro JM, Clotet B, Call Conference Group. J Antimicrob Chemother; 2012 Jun 25; 67(6):1462-9. PubMed ID: 22431669 [Abstract] [Full Text] [Related]
24. Importance of polar solvation and configurational entropy for design of antiretroviral drugs targeting HIV-1 protease. Kar P, Lipowsky R, Knecht V. J Phys Chem B; 2013 May 16; 117(19):5793-805. PubMed ID: 23614718 [Abstract] [Full Text] [Related]
25. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance. Hong L, Zhang XC, Hartsuck JA, Tang J. Protein Sci; 2000 Oct 16; 9(10):1898-904. PubMed ID: 11106162 [Abstract] [Full Text] [Related]
26. Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir. Yu Y, Wang J, Shao Q, Shi J, Zhu W. Sci Rep; 2015 May 27; 5():10517. PubMed ID: 26012849 [Abstract] [Full Text] [Related]
27. Persistence of mutations during replication of an HIV library containing combinations of selected protease mutations. Song W, Maeda Y, Tenpaku A, Harada S, Yusa K. Antiviral Res; 2004 Mar 27; 61(3):173-80. PubMed ID: 15168798 [Abstract] [Full Text] [Related]
28. Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations. Wittayanarakul K, Aruksakunwong O, Sompornpisut P, Sanghiran-Lee V, Parasuk V, Pinitglang S, Hannongbua S. J Chem Inf Model; 2005 Mar 27; 45(2):300-8. PubMed ID: 15807491 [Abstract] [Full Text] [Related]
29. Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor. Hu G, Ma A, Dou X, Zhao L, Wang J. Int J Mol Sci; 2016 May 27; 17(6):. PubMed ID: 27240358 [Abstract] [Full Text] [Related]
31. Revealing the drug resistance mechanism of saquinavir due to G48V and V82F mutations in subtype CRF01_AE HIV-1 protease: molecular dynamics simulation and binding free energy calculations. C S V, Munusami P. J Biomol Struct Dyn; 2023 Feb 27; 41(3):1000-1017. PubMed ID: 34919029 [Abstract] [Full Text] [Related]
32. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease. Gupta A, Jamal S, Goyal S, Jain R, Wahi D, Grover A. BMC Bioinformatics; 2015 Feb 27; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135 [Abstract] [Full Text] [Related]
34. Gated binding of ligands to HIV-1 protease: Brownian dynamics simulations in a coarse-grained model. Chang CE, Shen T, Trylska J, Tozzini V, McCammon JA. Biophys J; 2006 Jun 01; 90(11):3880-5. PubMed ID: 16533835 [Abstract] [Full Text] [Related]
35. Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations. Lepsík M, Kríz Z, Havlas Z. Proteins; 2004 Nov 01; 57(2):279-93. PubMed ID: 15340915 [Abstract] [Full Text] [Related]
36. Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics. Agniswamy J, Louis JM, Roche J, Harrison RW, Weber IT. PLoS One; 2016 Nov 01; 11(12):e0168616. PubMed ID: 27992544 [Abstract] [Full Text] [Related]
39. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments. Garriga C, Pérez-Elías MJ, Delgado R, Ruiz L, Nájera R, Pumarola T, Alonso-Socas Mdel M, García-Bujalance S, Menéndez-Arias L, Spanish Group for the Study of Antiretroviral Drug Resistance. J Med Virol; 2007 Nov 01; 79(11):1617-28. PubMed ID: 17854027 [Abstract] [Full Text] [Related]
40. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants. Majerová-Uhlíková T, Dantuma NP, Lindsten K, Masucci MG, Konvalinka J. J Clin Virol; 2006 May 01; 36(1):50-9. PubMed ID: 16527535 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]